Moclobemide Sandoz

Moclobemide, the active ingredient in Moclobemide Sandoz, is a monoamine oxidase inhibitor presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder and dysthymia in adult patients. The reversible inhibition of MAO‑A increases neurotransmitter availability, helping to alleviate depressive symptoms.

GNH USA supplies Moclobemide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclobemide acts on the monoamine oxidase pathway to treat depressive disorders. It is indicated for: - Major depressive disorder: alleviates depressive symptoms and improves mood. - Dysthymia (persistent depressive disorder): reduces chronic low mood and enhances daily functioning. - Depressive symptoms in adults: provides an alternative treatment option when other antidepressants are unsuitable.

Moclobemide may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: feeling light‑headed, especially on standing. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Hypertensive crisis: sudden high blood pressure, often triggered by tyramine‑rich foods. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities when combined with other serotonergic agents. - Severe liver injury: jaundice, elevated liver enzymes. - Agranulocytosis: marked reduction in white blood cells, increasing infection risk. - Severe skin reactions: such as Stevens‑Johnson syndrome.

Before initiating Moclobemide, clinicians should consider several safety measures. - Assess hepatic function: evaluate liver enzymes to detect pre‑existing impairment. - Monitor blood pressure: MAO inhibition can affect vascular tone. - Avoid tyramine‑rich foods: prevent hypertensive episodes. - Review concomitant serotonergic drugs: reduce risk of serotonin syndrome. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moclobemide interacts with several medication classes; some combinations must be avoided while others require close monitoring.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Meperidine or other opioids: may precipitate severe hypertension.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: can increase serotonergic activity. - Sympathomimetic agents (e.g., pseudoephedrine): may raise blood pressure. - St. John’s wort: may potentiate MAO inhibition and increase adverse effects.